Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04310644 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry

Study acronym: ProANS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 15, 2024 to Sep 15, 2028v5
  2. Eligibility criteria expanded, about 9 words
    • Study description expanded, about 13 words
    • Study arms: 4 to 5
    v4
  3. 2 versions Re-verified since May 9, 2022, no change to tracked fieldsv2-v3
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We examine patients with different autonomic neuropathies and Ehlers Danlos syndromes compared to healthy controls at three different points over time (baseline, after 3 months and after 1.5 years) to gain knowledge about the course of this disease and understand its pathophysiology, with a focus on Small Fiber neuropathy. Moreover we will validate the german version of the Malmö POTS Score and establish an easy diagnostic scheme for patients in outpatient care.
Trial Details
NCT Number NCT04310644
Lead Sponsor RWTH Aachen University
Collaborators: DLR German Aerospace Center
Conditions
(from sponsor)		 Autonomic Neuropathy, Ehlers-Danlos Syndrome Hypermobility Type, Small Fiber Neuropathy, Postural Tachycardia Syndrome
Related terms Ehlers-Danlos syndrome type 3, Postural Orthostatic Tachycardia Syndrome, Small Fiber Neuropathy
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov